These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 8650716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Progressive intermittent claudication is associated with impaired fibrinolysis.
    Killewich LA, Gardner AW, Macko RF, Hanna DJ, Goldberg AP, Cox DK, Flinn WR.
    J Vasc Surg; 1998 Apr; 27(4):645-50. PubMed ID: 9576077
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G.
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [Abstract] [Full Text] [Related]

  • 5. Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.
    Zunker P, Schick A, Padró T, Kienast J, Phillips A, Ringelstein EB.
    Neurol Res; 1999 Dec; 21(8):727-32. PubMed ID: 10596380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
    Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J.
    Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO, Abdullah A, Tahzeeb S.
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW, Catto AJ, Carter AM, Grant PJ.
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [Abstract] [Full Text] [Related]

  • 10. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K, Miura F, Sugino H, Shinobe M, Shirotani M, Yoshida H, Mori N, Hoshino T, Takada A.
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [Abstract] [Full Text] [Related]

  • 11. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
    Al-Hamodi Z, Ismail IS, Saif-Ali R, Ahmed KA, Muniandy S.
    Cardiovasc Diabetol; 2011 Mar 18; 10():23. PubMed ID: 21414238
    [Abstract] [Full Text] [Related]

  • 12. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke.
    Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Grilli M, Simone P, Panico S, Mancini M.
    Arterioscler Thromb; 1994 Nov 18; 14(11):1741-5. PubMed ID: 7947598
    [Abstract] [Full Text] [Related]

  • 13. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.
    Diabetes; 2000 Apr 18; 49(4):633-9. PubMed ID: 10871202
    [Abstract] [Full Text] [Related]

  • 14. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study.
    Macko RF, Kittner SJ, Epstein A, Cox DK, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, McCarter RJ, Johnson CJ, Earley CJ, Buchholz DW, Stolley PD.
    Stroke; 1999 Jan 18; 30(1):7-11. PubMed ID: 9880380
    [Abstract] [Full Text] [Related]

  • 15. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G.
    Circulation; 1998 Nov 24; 98(21):2241-7. PubMed ID: 9826309
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C.
    Stroke; 2005 Oct 24; 36(10):2077-81. PubMed ID: 16179568
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.
    Tofler GH, Massaro J, O'Donnell CJ, Wilson PWF, Vasan RS, Sutherland PA, Meigs JB, Levy D, D'Agostino RB.
    Thromb Res; 2016 Apr 24; 140():30-35. PubMed ID: 26896607
    [Abstract] [Full Text] [Related]

  • 19. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
    Pedersen OD, Gram J, Bagger H, Keller N, Jespersen J.
    Coron Artery Dis; 1994 Jul 24; 5(7):617-23. PubMed ID: 7952424
    [Abstract] [Full Text] [Related]

  • 20. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.
    Metabolism; 1997 Nov 24; 46(11):1287-93. PubMed ID: 9361687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.